Tampa, FL – Moffitt Cancer Center, the Tampa Bay Community Cancer Network (TBCCN), the Eliminating Disparities in Clinical Trials (EDICT) Initiative and the Intercultural Cancer Council (ICC) at Baylor College of Medicine will host a meeting on eliminating disparities in clinical trials. Tampa has been chosen as one of eight cities nationally to host a local forum to discuss the issue. The forum will be from 3 p.m. to 5 p.m. May 19 in the Ted & Marty Couch Auditorium in the Vincent A. Stabile Research Building at Moffitt. A networking reception will follow. This event is free and open to the public. For more information contact Shalewa Noel-Thomas at (813) 745-6813 or email@example.com.
Coming at a time when less than 1 percent of the U.S. population, or an estimated 2.3 million Americans, takes part in the 80,000 medical research studies conducted every year in the United States, the Tampa forum will confront two major topics of importance: older adults in clinical trials, and the importance of culture and literacy in clinical trials.According to the report issued by EDICT in April 2008, lack of community involvement in the clinical trials process is a major reason that the makeup of research studies does not mirror those in the population, especially women, older people, and racial and ethnic minorities.
The target audience for this event includes community members, patient advocates, health care providers, researchers, community stakeholders, advocates and educators. The goal of the forum is to engage the audience in a meaningful dialogue on solutions for eliminating disparities in clinical trials.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.
The Tampa Bay Community Cancer Network (TBCCN) is a partnership of the H. Lee Moffitt Cancer Center & Research Institute and several diverse local organizations such as community-based, faith-based, adult education and federally funded clinics and other organizations. Together, the goal of this network (www.tbccn.org) is to impact the cancer disparities that affect the medically underserved in the Tampa Bay community.
About EDICT & ICC
EDICT is spearheaded by the Chronic Disease Prevention and Control Research Center (CDPCRC) at Baylor College of Medicine in Houston and the Intercultural Cancer Council (ICC), an advocacy organization working to eliminate the unequal burden of cancer among racial and ethnic minorities and medically underserved populations. Eliminating Disparities in Clinical Trials (EDICT) is a four-year initiative (2005-2009) funded with an unrestricted educational grant from Genentech, Inc. to improve participation of minority and underserved patients in clinical trials.